🚨Listen to the latest Neurotech Pub episode with host Matt Angle and neurotech leaders Mary Lou Jepsen from Openwater, Ryan Field from Kernel, and Sumner L Norman from Forest Neurotech. From revolutionary brain-computer interfaces to pioneering mental health solutions, this talk dives deep into the cutting-edge innovations shaping the future of neurotechnology. Tune in for a mind-blowing discussion! 🧠🎙️ https://lnkd.in/gMrFt3XA #NeurotechPub #Innovation #BCI
Paradromics Inc.
Biotechnology Research
Austin, Texas 17,004 followers
Building a high data-rate brain computer interface (BCI) to provide technology solutions to unmet medical needs.
About us
CONNECTING THE HUMAN BRAIN What if we could restore or enhance function using the power of AI and advanced technology? Our direct data interface enables this connection. MISSION We are building a high data-rate brain computer interface (BCI) to provide technology solutions for people with neurological and brain-related conditions. Our first clinical application will help severely motor-impaired people communicate, enabling social connection and restoring independence. ABOUT Paradromics was founded in 2015 by a team of engineers and neuroscientists, received early support from both NIH and DARPA, and is currently backed by venture capital.
- Website
-
www.paradromics.com
External link for Paradromics Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Austin, Texas
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Neural Interfaces, Brain Computer Interface, Assistive Communication Devices, Direct Data Interface, DDI, BCI, and Neuroscience
Products
Locations
-
Primary
4030 W Braker Ln
Austin, Texas 78759, US
Employees at Paradromics Inc.
-
Adam Weiss
Staff Research Engineer @ Paradromics
-
Daren Martin
WSJ, USA Today & Amazon Bestselling Author | Motivational Keynote Speaker | Executive Coach | C-Suite Advisor | Global Company Culture Association…
-
Ken Walker
Director, Medical Services
-
Matt Marino
Vice President Finance at Paradromics Inc
Updates
-
NeuraSeed BCI Expo 2024 is this Friday! 🧠 Don’t miss out on presentations by leaders in the BCI space like Paradromics CSO Vikash Gilja, Dr. Benjamin Rapoport, Co-Founder & CSO at Precision Neuroscience, Rob Franklin, VP BCI at Blackrock Neurotech, Dr. J Mocco, CMO at Synchron, and Nicolas Vachicouras, CEO at Neurosoft Bioelectronics. 👇 Register here to learn more about cutting edge research and innovations in #BCI: https://lnkd.in/gmcexdMN
-
“When people who have to use assistive communication tools that are very laborious, they get in a situation where it becomes just tiring to communicate,” said Matt Angle, the founder of a brain chip startup that is working on a solution to this problem. “And so they don’t have casual conversations with their loved ones as much as they used to. It ends up being very goal oriented, very needs driven.” Learn more about how our Connexus® Direct Data Interface will enable people who have lost the ability to speak and beyond. https://lnkd.in/g-GbXS3R
A Neuralink rival wants to give people who can't talk their voices back with a high-tech brain chip
qz.com
-
#BCI technology is advancing in impactful ways thanks to the collaborative spirit of the FDA and the diverse stakeholders within the BCI field. In our latest blog posts, read more about the Implantable Brain Computer Interface Collaborative Community (iBCI-CC) and the role of the FDA in ensuring more rapid development and patient access to safe, effective, high-quality brain computer interface technology. iBCI-CC: Empowering Through Collaboration 👇 https://lnkd.in/gAcx5JPB The Role of FDA in the BCI Journey👇 https://lnkd.in/gpq4XgBu
iBCI-CC: Empowering Through Collaboration | NeuroExplainer
paradromics.com
-
We are looking forward to Vikash Gilja participating in an informative panel this Thursday at IEEE Engineering Medicine and Biology Society 2024!
#BCI - State of the Art, Art of the Future. We're back for another year of BCI vision, mission, and reality. Come to #EMBC2024 on July 18 to hear from execs from the companies leading the BCI field. https://lnkd.in/gxjZg4Du
-
Thanks Ashley Capoot! Great article featuring Paradromics on CNBC's Healthy Returns. https://lnkd.in/gCvt4WCX
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
cnbc.com
-
🚨 Don't miss the season 3 premiere of Neurotech Pub! Join our CEO, Matt Angle, and leading experts Jacob Robinson from Motif Neurotech, Grayson Z. from Resonant Link, and Alexander Yeh from Neuspera Medical Inc. as they discuss the groundbreaking developments in wireless power technologies for implantable devices. From high data rate brain-computer interfaces to life-changing mental health treatments, this episode is packed with insights on the future of neurotech. 🎙️🧠 Listen to the full episode: https://lnkd.in/gdDjG_6e #NeurotechPub #BCI
-
Great recap on the Neurotech industry in June. Thanks Naveen Rao! Be sure to subscribe to Neurotech Futures for an in-depth exploration of the emerging field of neurotechnology and its impact on brain health, markets, and ethics. https://lnkd.in/g9cjYvQV
Neurotech Notables #11: June 2024
neurotechnology.substack.com
-
📣 Exciting news! Paradromics has been accepted into the U.S. FDA’s newest accelerator program (TAP) and we have received our second Breakthrough Device Designation! These programs offer an expedited review process for transformative medical devices (like #BCIs 🧠). Matthew Willsey, MD, PhD, a leading neurosurgeon at the University of Michigan Medical School stated, “I’m excited to see BCI technologies, such as the Connexus® device, entering the clinical phase. This is one step closer to restoring movement to people with paralysis, or speech to those who have lost this function.” In preparation for our clinical trials in 2025, we have also launched the Paradromics Community, where patients, caregivers, and allies can stay up-to-date about current and future applications of Paradromics’ core technology. Read the full press release: https://lnkd.in/gWyjBpM4
Paradromics accepted to FDA regulatory accelerator program and announces new patient registry
prnewswire.com
-
“But, this isn’t just about profit – it’s also about this tech’s potential to change our daily lives, revolutionize the medical field, and even impact the course of human evolution.” Great informative video on the #neurotech industry and the current competitive landscape, Morning Brew! Shoutouts to Jacob Robinson, Founder & CEO Motif Neurotech, Ian Burkhart, and Harrison Canning 🧠, neurotechnologist at the The BCI Guys! It’s an exciting time in #BCI. Watch the full video: https://lnkd.in/gcv7Gazc
Companies Are Racing To Put A Chip In Your Brain
https://www.youtube.com/